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1607-551X/Copyright ª 2015, KaohsiuAbstract This experiment was conducted to investigate the role of EPH receptor A2 (EphA2)
in the modulation of radiosensitivity of hepatic cellular cancer (HCC) cells and to determine
whether p38/mitogen-activated protein kinase (p38MAPK) signaling mediated EphA2 function
in this respect. The protein expressions of EphA2 and phosphorylated p38MAPK were tested in
HCC and normal hepatic tissues. In HCC 97H cells, EphA2 was overexpressed and knocked out
by transfection with EphA2 expression vector and EphA2-ShRNA, respectively, prior to cell
exposure to low-dose irradiation. Significantly upregulated EphA2 and phosphorylated
p38MAPK were observed in HCC tissues, compared with those in normal hepatic tissues.
Low-dose irradiation (1 Gy) only caused minor damage to HCC 97H cells, as assessed by alter-
ations in cell viability, apoptosis rate, and cell healing capacity (p Z 0.072, p Z 0.078, and
pZ 0.069 respectively). However, EphA2 knock-out in HCC 97H cells induced significant reduc-
tion in cell viability and cell healing capacity after these cells were subjected to low-dose irra-
diation. Apoptosis rate underwent dramatic increase (p < 0.01). By contrast, EphA2
overexpression in HCC 97H cells reversed these effects and enhanced cell colony formation
rate, thus displaying remarkable attenuation of radiosensitivity of HCC 97H cells. Further,
SB203580, a specific inhibitor of p38MAPK, was added to HCC 97H cells over-expressing EphA2.
The effect of EphA2 overexpression on the radiosensitivity of HCC 97H cells was abrogated.
Thus, the present study indicates that EphA2 have the ability to negatively regulate the radio-
sensitivity of HCC 97H cells, which mainly depends on 38MAPK-mediated signal pathways.
Copyright ª 2015, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
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Hepatocellular carcinoma (HCC) is a serious health prob-
lem. More than 600,000 new cases are diagnosed every year
worldwide, yet a safe and effective therapy remains to be
identified [1]. Conventional radiotherapy, for example, has
played a limited role in HCC treatment during the past few
decades, because of the low tolerance of nontumoral liver
parenchyma to strong radiation as well as the high risk from
radiation-induced deterioration of pre-existing diseases
such as liver cirrhosis (the occurrence of HCC is commonly
observed with the presence of cirrhosis and other relevant
conditions) [2,3]. Low-dose radiotherapy is a recent
advance in the field of radiotherapy that comes with a set
of adjuvant therapies, including the key strategy of sensi-
tizing cancer cells to irradiation to achieve therapeutic
effects similar to those observed with traditional high-dose
radiotherapy, but with less toxicity to neighboring innocent
organs and tissues. However, at present, poor understand-
ing of the precise mechanisms involved in regulating the
radiosensitivity of HCC cells impedes extensive application
of low-dose radiotherapy to clinical settings.
EPH receptor A2 (EphA2), an important member of the
Eph receptor family, has been observed to be highly
expressed in diverse kinds of cancers such as breast cancer,
prostate cancer, lung cancer, malignant glioma, and gastric
cancer; this triggers extensive interest in its potential role
in cancer [4]. Previous literature shows overexpression of
EphA2 correlates with cancer progression and lymphoge-
nous metastasis in gastric cancer [5]. Moreover, an analysis
of EPHA2-knock-out mice indicated their deficiency in the
ability to support the invasion and metastasis of implanted
tumors [6]. This evidence indicates that upregulation of
EphA2 confers properties such as increased cancer motility,
invasiveness, and metastasis. Furthermore, emerging evi-
dence shows that EphA2 blockade enhances the anti-
endothelial effect of radiation and inhibits irradiated tumor
cell-induced migration of endothelial cells, implying that
EphA2 probably gives cancer cells an opportunity to escape
radiation stress [7].
P38/mitogen-activated protein kinase (p38MAPK),
belonging to the MAPK family, has been implicated in the
regulation of cell proliferation and apoptosis after exposure
to irradiation. P38MAPK inhibition after treatment with a
specific chemical inhibitor completely attenuated the
mitochondrial translocation of Bax in response to radiation,
suggesting that p38MAPK is involved in radiation-induced
mitochondrial apoptotic cell death, whereas there is evi-
dence that p38MAPK restores homeostasis in UV-stressed
cells and facilitates cell survive via cell cycle arrest and
DNA repair [8,9]. It is believed that the ability of p38MAPK
to determine cell fate, between cell survival and apoptotic
cell death, correlates with the extent of radiation stress.
Under overwhelming stress conditions, p38MAPK is more
likely to activate p53 and other signal pathways to induce
apoptosis. However, if the level of radiation is low or not
too high, p38MAPK probably chooses other pathways to help
maintain cell survival [9]. Thus, p38MAPK is proposed to be
an important therapeutic target in low-dose radiotherapy.
In this study, the protein expressions of EphA2 and
phosphorylated p38MAPK (p-p38MAPK) were tested in HCCtissues (these tissues were obtained from patients with
poorly differentiated HCC) to compare with those in normal
hepatic tissues. Next, we conducted our experiment in HCC
97H cell line, which was established from high malignant
HCC cells and exhibits strong proliferation, migration, and
invasion abilities [10,11]. EphA2 in HCC 97H cell line was
artificially up- or downregulated via the transfection with
EphA2 expression vector or EphA2-small hairpin RNA
(EphA2-shRNA) to provide an insight on the role of EphA2 in
the modulation of HCC radiosensitivity. It was found that
HCC radiosensitivity is negatively correlated with EphA2
expression. The specific inhibitor of p38MAPK signal,
SB203580, was added to the EphA2-overexpressing group to
explore further whether p38MAPK mediated the function of
EphA2, which is serving as the radioresistance promoter.
The aim of this study was to lay a theoretical foundation for
the modulation of the radiosensitivity of HCC cells during
low-dose radiotherapy.
Methods
Ethics statement
This study was approved by the Ethics Committee of Xian-
gya Medical School (Changsha, China). All patients provided
written informed consent in compliance with the code of
ethics of the World Medical Association (Declaration of
Helsinki; Ferney-Voltaire, France).
Tissue treatment and cell culture
Twenty tissue specimens from HCC tissues (n Z 10) and
normal hepatic tissues (n Z 10) were obtained from the
Xiangya Medical School. Western blotting was used to
detect the protein expressions of EphA2 and p-p38MAPK in
both tissue types. Human HCC 97H cell line was purchased
from the American Type Culture Collection (Manassas, VA,
USA). Cells were cultured in Dulbecco’s modified Eagle’s
medium (Gibco-BRL, Grand Island, NY, USA) supplemented
with 10% fetal bovine serum (Gibco-BRL) in a 37C incubator
with 5% CO2.
Western blotting
Cell extracts were prepared by using the lysis buffer con-
taining 1% NP-40, 0.1% sodium dodecyl sulfate, 50mM
dithiothreitol, 2 mg/mL aprotinin, 2 mg/mL leupeptin, and
1mM phenylmethane sulfonylfluoride. Total protein con-
centration was measured using the bicinchoninic acid pro-
tein assay kit (Pierce, Rockford, IL, USA) to ensure that
equal amounts of protein were separated by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis. The
proteins separated on electrophoresis gels were transferred
to nitrocellulose membranes (Millipore, Billerica, MA, USA)
and these membranes were blocked in phosphate-buffered
saline containing 0.1% Tween 20 and 5% powdered milk and
probed with primary antibody directed against Epha2,
p38MAPK, p-p38MAPK (Tyr 182), and b-actin (Santa Cruz
Biotechnology, Inc., Santa Cruz, CA, USA). Thereafter, the
membranes were washed and incubated with peroxidase-
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G secondary antibody (Santa Cruz Biotechnology, Inc.) at a
dilution of 1:20,000.
Transfection and drug treatment
An open reading frame clone of homo EphA2 was subcloned
into enhanced green fluorescent protein plasmid-C1 vector
to construct EphA2 expression vector (Invitrogen Life
Technologies, Carlsbad, CA, USA). Small hairpin RNA tar-
geting EphA2 was synthesized by GenePharma Co., Ltd
(pGPU6/GFP/Neo-EPHA2-homo-310; Shanghai, China) as
follows: GGGACCTGATGCAGAACATCA. ShRNA duplexes
containing nonspecific sequences (pGPU6/GFP/Neo-shNC)
were used as a negative control: GTTCTCCGAACGTGT-
CACGT. EphA2 expression vector and EphA2-shRNA were
added to the culture medium and transfected into HCC 97H
cells using Lipofectamine 2000 (Invitrogen Life Technolo-
gies), according to the manufacturer’s instructions. One
group of HCC 97H cells transfected with EphA2 expression
vector was treated with SB203580 (p38MAPK signal-specific
inhibitor) (Calbiochem, Darmstadt, Germany). SB203580
solution was prepared by dissolving it in the culture me-
dium to a final concentration of 5mM.
Irradiation
In our pilot experiment, HCC 97H cells were exposed to
different doses of ionizing radiation (0 Gy, 1 Gy, 2 Gy, 4 Gy,
or 8 Gy). Briefly, HCC 97H cells were seeded into T-25 flasks.
After 48 hours’ incubation, the exponentially growing cells
were cultured in the media without fetal bovine and irra-
diated with 6 MeV photons/20 cm focusesurface distance at
a dose rate of 2 Gy/min at room temperature. The irradia-
tion range was restricted in 20 cm  20 cm. The total
amount of irradiation that HCC 97H cells suffered from was
set up as 0 Gy, 1 Gy, 2 Gy, 4 Gy, or 8 Gy separately. After the
irradiation, the cells were cultivated for 72 hours, which
allowed sufficient time for the generation of irradiation-
induced cytotoxicity. Relative tests showed that 1 Gy irra-
diation only induced minor decrease in cell viability and cellFigure 1. Viability of HCC 97H cells after exposure to differen
different doses of irradiation. (B) EphA2 expression vector and EphA
97H cells transfected with EphA2 expression vector was treated with
subjected to irradiation (dose Z 1 Gy), followed by the test to
EphA2 Z EphA2 expression vector; Ir Z irradiation; SBZ SB20358wound healing capacity (Figures 1A and 2A), though the cell
colony formation rate underwent dramatic reduction
(Figure 3A). This means that irradiation at this level is still
insufficient to pose effective damage to HCC 97H cells. With
the elevation of irradiation, however, damage inflicted by
radiation was gradually enhanced. Finally, 1 Gy irradiation
was selected and used in our formal experiment.Cell viability assay
The cells seeded at a density of 1  105 cells/well into 96-
well plates were cultured with 100 mL of culture medium
per well for 24 hours and with 90 mL of culture medium plus
10 mL CCK-8 reagents per well for 1 hour. The optical
density at 490 nm (OD490 nm) for each well was determined
by an enzyme immunoassay analyzer.Annexin V-FITC/propidium iodide double-staining
After irradiation, the cells were double-stained with
Annexin V-FITC and propidium iodide, according to the
manufacturer’s instruction (Solarbio, Bei Jin, China), and
then analyzed with a dual laser flow cytometer (Becton
Dickinson, San Jose, CA, USA). The extent of apoptosis was
estimated using ModFit LT software (Verity Software House,
Topsham, ME, USA).Wound healing assay
Cells were trypsinized and seeded in 6-well plates, and
each well was divided into a 2  3 grid after the cells
reached confluence. An artificial homogenous wound was
created by scratching the cell monolayer with a 1-mL
pipette tip and exposing cells to low-dose irradiation. The
culture medium was replaced with FBS-free medium in the
next round of cultivation. Microscopic images of the same
area were captured immediately after a wound was inflic-
ted as well as at 24 hours. Cell migration rate was calcu-
lated using the following equation:t treatments. (A) Viability of HCC 97H cells after exposure to
2-ShRNA were transfected into HCC 97H cells. One group of HCC
SB203580, a specific inhibitor of p38MAPK. Next, HCC 97H cells
viability. Bars not sharing a common letter differ (p < 0.05).
0; ShEphA2 Z EphA2-small hairpin RNA.
Figure 2. Migration rate of HCC 97H cells after exposure to different treatments. (A) Migration rate of HCC 97H cells after exposure to
different doses of irradiation was obtained by wound healing test. (B) EphA2 expression vector and EphA2-ShRNAwere transfected into
HCC 97H cells. One group of HCC 97H cells transfected with EphA2 expression vector was treated with SB203580, a specific inhibitor of
p38MAPK. Next, HCC 97H cells subjected to irradiation (doseZ 1 Gy), followed bywound healing test. Bars not sharing a common letter
differ (p < 0.05). EphA2Z EphA2 expression vector; IrZ irradiation; SBZ SB203580; ShEphA2Z EphA2-small hairpin RNA.
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After irradiation, cells were plated on soft agar and incubated
for 1 week to allow colony growth. Colonies were stainedwith
crystal violet and images of the stained plates were captured.
Colonies > 75 mm in diameter or containing > 50 cells were
counted as one positive colony. Colony formation rate was
calculated using the following equation: positive colony
number/cells that originally seeded in the plate.
Statistical analysis
Data from these experiments were analyzed by SPSS version
12.0 software (IBM, Armonk, NY, USA). The results of theexpressions of indicated proteins in HCC tissues and normal
hepatic tissues are presented as the mean  standard error
of the mean (nZ 10) after evaluation by unpaired Student
t test; other results are presented as the mean  standard
error of the mean of three independent experiments, and
one-way analysis of variance (ANOVA) with post hoc testing
was used for multiple comparisons between each group.
Significant differences were established at p < 0.05.Results
Protein expression levels of EphA2, p38MAPK, and
p-p38MAPK
According to results of western blotting (Figure 4A),
significantly upregulated EphA2 and p-p38MAPK were
Figure 3. Colony formation rate of HCC 97H cells after exposure to different treatments. Colony formation rate of HCC 97H cells
after exposure to different doses of irradiation. (B) EphA2 expression vector and EphA2-ShRNA were transfected into HCC 97H cells.
One group of HCC 97H cells transfected with EphA2 expression vector was treated with SB203580, a specific inhibitor of p38MAPK.
Next, HCC 97H cells subjected to irradiation (dose Z 1 Gy), followed by the test to colony formation rate. Bars not sharing a
common letter differ (p < 0.05). EphA2 Z EphA2 expression vector; Ir Z irradiation; SBZ SB203580; ShEphA2 Z EphA2-small
hairpin RNA.
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hepatic tissues (p < 0.05). In Figure 4B, HCC 97H cells
exposed to low-dose irradiation (1 Gy) showed minor ef-
fects on relative expression levels of EphA2, p38MAPK, and
p-p38MAPK compared to the control (pZ 0.068, pZ 0.073,
and p Z 0.071). Cells transfected with EphA2 expression
vector or EphA2-shRNA before irradiation significantly
upregulated or downregulated the relative expression of
EphA2 and p-p38MAPK. Adding the specific inhibitor of
p38MAPK, SB203580, into cells transfected with EphA2
expression vector failed to alter EphA2 overexpression, but
it remarkably inhibited the relative expression of p-
p38MAPK (p < 0.05). Our trials showed no marked differ-
ence in p38MAPK expression between each group.Cell viability and apoptosis rate
Postirradiation cell viability and apoptosis rate are shown in
Figures 1 and 5, respectively. As can be noted from our
data, HCC 97H cells exposed to irradiation at a dose of 1 Gy
only did not significantly affect cell viability and apoptosis
rate. Postirradiation cell viability was much higher in HCC97H cells transfected with EphA2 expression vector,
compared to the nontreated cells (p < 0.05), but much
lower in HCC 97H cells transfected with EphA2-shRNA
(p < 0.05). SB203580 treatment abolished the beneficial
effect of overexpressed EphA2 on cell viability. With
respect to postirradiation apoptosis rate, HCC 97H cells
transfected with the EphA2 expression vector exhibited
dramatic reduction, compared to the nontreated cells; this
decrease was not observed after treatment with SB203580.
What needs special mention is that expressional inhibition
of EphA2 greatly augmented the apoptosis rate (p < 0.01).
Wound healing capability and cell colony formation
rate
After irradiation, the cells transfected with EphA2 expres-
sion vector had higher migration rate compared to non-
transfected cells (p < 0.05), whereas SB203580-treated
cells showed a rate similar to that of nontransfected cells
(Figure 2). EphA2-shRNA-transfected cells showed a
considerable decrease in migration rate. In Figure 3B, 1 Gy
irradiation triggered significant decrease in cell colony
Figure 4. Relative protein expression levels of indicated proteins in HCC and normal hepatic tissues and in HCC 97H cells that
received different treatments. (A) Relative protein expression levels of EphA2 and p-p38MAPK in HCC tissues (n Z 10) compared
those in normal hepatic tissues (n Z 10). Bars with marks * and # have significant difference from normal groups (p < 0.05). (B)
EphA2 expression vector and EphA2-ShRNA were transfected into HCC 97H cells. One group of HCC 97H cells transfected with EphA2
expression vector was treated with SB203580, a specific inhibitor of p38MAPK. Next, HCC 97H cells were subjected to irradiation
(dose Z 1 Gy). As there was no significant difference in the relative protein expression level of p38MAPK across groups receiving
different treatments, this result was excluded. Bars not sharing a common letter differ (p < 0.05). Cancer Z HCC tissues;
EphA2 Z EphA2 expression vector; Ir Z irradiation; normal Z normal hepatic tissues; p38 Z p38MAPK; p-p38 Z p-p38MAPK;
SBZ SB203580; ShEphA2 Z EphA2-small hairpin RNA.
EphA2 modulates radiosensitive 515formation rate, but this inhibitory effect was abolished by
the transfection with EphA2 expression vector. EphA2
knock-out only marginally enhanced the detrimental effect
of 1 Gy irradiation in terms of cell colony formation.Discussion
In the present study, EphA2 that was shown to be upregu-
lated in HCC tissues plays a significant role in the modula-
tion of HCC 97H cells radiosensitivity. In HCC 97H cells,
overexpressing EphA2 via the transfection of EphA2
expression vector (without SB203580 treatment) simulta-
neously potentiated cell viability and attenuated apoptosisrate after exposure to low-dose irradiation. Conversely,
EphA2 knockdown by transfection of EphA2-ShRNA
rendered HCC vulnerable to irradiation, resulting in lower
cell viability and extremely high apoptosis rate. These data
indicate that EphA2 contributes to the development of
resistance to the cytotoxicity of radiation in HCC.
Furthermore, in the wound healing test where cells were
subjected to artificial injury and allowed to recover and
proliferate in the next round of cultivation in order to
reflect the healing capacity of cells, HCC migration rate
was found to be positively correlated with the expression
level of EphA2. Given the fact that the higher the cell
migration rate, the stronger the healing capacity, EphA2
can promote cell healing capacity to attenuate the
Figure 5. Apoptosis rate of HCC 97H cells after exposure to different treatments. EphA2 expression vector and EphA2-ShRNA
were transfected into HCC 97H cells. One group of HCC 97H cells transfected with EphA2 expression vector was treated with
SB203580, a specific inhibitor of p38MAPK. Next, HCC 97H cells subjected to irradiation (doseZ 1 Gy). (A) Flow cytometry images
of HCC 97H cells exposed to different treatments. (B) Apoptosis rate of HCC 97H cells exposed to different treatments. Bars not
sharing a common letter differ (p < 0.05). EphA2Z EphA2 expression vector; IrZ irradiation; SBZ SB203580; ShEphA2Z EphA2-
small hairpin RNA.
516 Q. Jin et al.radiosensitivity of HCC. As an important index to reflect
carcinogenesis [12], colony formation rate was significantly
decreased following HCC 97H cell exposure to 1 Gy irradi-
ation, but transfection with EphA2 expression vector
restored cell colony formation rate to basal level. This
means overexpressing EphA2 violates the inhibitory effect
of low-dose irradiation (1 Gy) on carcinogenesis of HCC.
EphA2 is a receptor tyrosine kinase that has been identified
to induce pro-oncogenic effects, including enhancing
tumorigenesis, tumor cell migration and invasion, angio-
genesis, and metastasis [13], but few or no reports shows
that EphA2 can diminish radiosensitivity. Our results herein
broaden the view of EphA2 serving as a cancer supporter.
Radiotherapy represents an effective therapy for can-
cer, but it comes along with many side-effects; more
importantly, tumor cells possess different mechanisms toescape cell death and defend against the cytotoxic effect
of irradiation, especially at a low dose [4]. According to
existing literature, the mechanisms underlying resistance
to irradiation in cancer cells include, at the least, DNA
repair, cell cycle arrest, antioxidant system enhancement
and growth signal activation, and cell death signal inhibi-
tion [14]. Thus, the effect of EphA2 overexpression on
resistance to irradiation in HCC cells suggests that some of
these mechanisms are employed.
P38MAPK signals are known to be regulated by the Eph
receptor family members. Upregulated EphA2 causes
p38MAPK activation in endothelial progenitor cells [15]. In
the current study, p-p38MAPK was shown to be dramatically
upregulated in HCC tissues. To identify the role of p38MAPK
in EphA2 function, a specific inhibitor of p38MAPK, namely
SB203580, was added to EphA2-over-expressing cells.
EphA2 modulates radiosensitive 517Activation of p38MAPK requires phosphorylation of Tyr182
[16]. Our results showed that the level of phosphorylation
of p38MAPK at Tyr182 was considerably inhibited following
the addition of SB203580, and more importantly, that
EphA2-led enhancement of HCC radioresistance was
blocked, suggesting that the functions exerted by EphA2
mainly relied on p38MAPK-mediated signal pathways.
P38MAPK can exert growth-promoting effects in
different ways. P38MAPK provides an advantage for cell
survival by regulating the cell cycle checkpoints, including
G1/S and G2/M [9]. Irradiation causes the generation of
substantial oxidative free radicals, which pose strong
toxicity to DNA via the deterioration of its original molec-
ular structures, while the cell cycle checkpoints allow time
for DNA repair [17,18]. Furthermore, p38MAPK has been
associated with diverse kinds of key signal factors deter-
mining cell survival and death fates, such as STAT1, AP-1,
cAMP-response element-binding protein, p53, nuclear fac-
tor-kB, and b-catenin [18]. It should be noted that,
although p38MAPK is widely confirmed to have the ability to
strengthen cell survival, the precise mechanisms mediated
by p38MAPK involved in our experiment warrant further
investigation. Besides, in our future study, the roles of
EphA2 and p38MAPK in the modulation of radiosensitivity
were detected in other types of HCC cell lines and HCC cell
tumor xenografted nude mice to validate the mechanisms
demonstrated by our experiment extensively exist in HCC
cells.
In summary, significantly upregulated EphA2 and down-
regulated p-p38MAPK were observed in HCC tissues,
compared with those in normal hepatic tissues. In HCC 97H
cells, overexpressing EphA2 via the transfection of EphA2
expression vector attenuated radiosensitivity, with a
remarkable increase in cell viability and healing capacity,
and decreased apoptosis rate after low-dose irradiation of
cell; these effects were abrogated by treatment with
SB203580, a specific inhibitor of p38MAPK signals. The
knock-out of EphA2 caused lower cell viability and healing
capacity and higher apoptosis rate. Our findings collectively
suggest that EphA2 is able to modulate HCC radiosensitivity
adversely, mainly via its important downstream target,
namely, p38MAPK. The molecular mechanism elucidated in
this study may contribute to the design of future cancer
therapies to bypass the adverse impacts of EphA2 on
radiosensitivity.
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